Talal Dahhan to Pulmonary Artery
This is a "connection" page, showing publications Talal Dahhan has written about Pulmonary Artery.
Connection Strength
1.090
-
Abdulelah M, Ezenna C, Jenil-Franco A, Jamouss KT, Krishna MM, Joseph M, Chi KY, Dahhan T. Clinical outcomes and safety of sotatercept in pulmonary arterial hypertension: A systematic review and meta-analysis of randomized controlled trials. Vascul Pharmacol. 2025 Sep; 160:107520.
Score: 0.898
-
Parikh KS, Doerfler S, Shelburne N, Kennedy K, Whitson J, Dahhan T, Fortin T, Rajagopal S. Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension. J Cardiovasc Pharmacol. 2020 04; 75(4):299-304.
Score: 0.156
-
Awerbach JD, Stackhouse KA, Lee J, Dahhan T, Parikh KS, Krasuski RA. Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance. Respir Med. 2019 04; 150:126-130.
Score: 0.036